About the Role
The Sr. Director, Clinical Data Management provides strategic and operational leadership for the Clinical Data Management function, establishing a scalable function that delivers high-quality clinical trial data to support development milestones, regulatory submissions, and future portfolio growth in a lean biotechnology environment.
Responsibilities
- Lead the Clinical Data Management function by developing and executing strategies, processes, and operational plans.
- Oversee Clinical Data Management activities, including review and approval of key deliverables such as database design, eCRFs, edit checks, data review plans, and database lock activities.
- Lead data review, issue management, and milestone readiness to support interim analyses, database locks, and key development milestones.
- Serve as the primary escalation point for data management issues affecting study quality, timelines, or regulatory readiness.
- Oversee EDC and related clinical data systems, including implementation, configuration, and vendor management.
- Lead the selection, oversight, and performance management of CROs and specialty vendors, establishing governance, performance metrics, and communication processes.
- Manage vendor budgets and identify cost-effective solutions without compromising quality or compliance.
- Drive continuous improvement initiatives that enhance data quality, operational efficiency, and study execution.
- Partner with Clinical Operations, Biostatistics, Statistical Programming, Clinical Science, Medical, Safety, Regulatory, and Quality to support successful study execution.
- Provide data management expertise during protocol development, advising on data collection strategy, endpoint feasibility, and study design.
- Ensure clinical data are inspection-ready and support regulatory submissions, audits, safety reviews, and due diligence activities.
- Contribute to a culture that reflects ALX's values by acting with integrity, accountability, transparency, and respect.
- Build strong, collaborative relationships through active engagement with colleagues, including regular onsite participation consistent with the company's hybrid work model.
Requirements
- Approximately 12+ years of progressive Clinical Data Management experience within biotechnology, pharmaceutical, or CRO environments, including Phase I-III clinical studies.
- Demonstrated success leading outsourced Clinical Data Management activities, partnering across functions, and delivering high-quality clinical trial data.
- Experience supporting regulatory submissions is preferred.
- Oncology and/or immuno-oncology experience is strongly preferred.
- Strong knowledge of Clinical Data Management principles, GCP, applicable regulatory requirements, CDISC standards, and industry best practices.
- Demonstrated expertise in database design, data cleaning, medical coding, external data reconciliation, data review, database lock, and other core Clinical Data Management processes.
- Experience with leading EDC platforms such as Medidata Rave, Veeva EDC, Oracle Clinical, or equivalent systems.
- Demonstrated ability to effectively manage CROs, vendors, budgets, and outsourced Clinical Data Management activities.
- Strategic, collaborative leader with excellent communication, organizational, and relationship-building skills, capable of influencing cross-functional teams and external partners.
- Demonstrated ability to prioritize competing demands, solve complex problems, build scalable processes, and adapt to evolving business priorities while contributing beyond functional boundaries in a fast-paced, resource-constrained environment.
Skills
- Medidata Rave
- Veeva EDC
- Oracle Clinical
- CDISC standards
- GCP
- Clinical Data Management principles
Location
- South San Francisco, CA
Work Type
- Hybrid
Experience Level
- 12+ years
Education Level
- Bachelor's degree in Life Sciences, Statistics, Computer Science, or a related scientific discipline, or an equivalent combination of education and directly relevant work experience.
- Advanced degree (MS, MPH, PhD) is a plus.
Salary/Compensations
- $240,000 - $280,000
Benefits
- Stock programs
- Performance-based bonus
- Comprehensive benefits package including 401K
About the Company
- ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives.
- ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built.
- Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.
- ALX Oncology’s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action.
- A Phase 1, dose-escalation trial of ALX2004 is ongoing in patients with EGFR-expressing solid tumors.
- More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology.
Equal Opportunity
- ALX Oncology does not accept unsolicited resumes or candidate information from recruitment agencies, including blinded or anonymized resumes, and will not be responsible for any fees associated with unsolicited submissions.
- Do not contact hiring managers or other ALX Oncology employees directly.
- Recruiting activities are managed through our Human Resources team.
